Role of CD5⁺ B-1 cells in EAE pathogenesis

References

• Askenase PW, Szczepanik M, Itakura A, Kiener C, Campos RA. Extravascular T-cell recruitment requires initiation begun by Vα14+ NKT cells and B-1 B cells. Trends Immunol 2004; 25: 441–449
   PubMed Web of Science ®Google Scholar
• Hardy RR, Hayakawa K. Development and physiology of Ly-1 B and its human homolog, Leu-1 B. Immunol Rev 1986; 93: 53–79
   PubMed Web of Science ®Google Scholar
• Herzenberg LA, Stall AM, Lalor PA, Sidman C, Moore WA, Parks DR, Herzenberg LA. The Ly-1 B cell lineage. Immunol Rev 1986; 93: 81–102
   PubMed Web of Science ®Google Scholar
• Stall AM, Adams S, Herzenberg LA, Kantor AB. Characteristics and development of the murine B-1b (Ly-1 B sister) cell population. Ann N Y Acad Sci 1992; 651: 33–43
   PubMedGoogle Scholar
• Hardy RR. B-1 B cell development. J Immunol 2006; 177: 2749–2754
   PubMed Web of Science ®Google Scholar
• Hayakawa K, Hardy RR, Stall AM, Herzenberg LA, Herzenberg LA. Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur J Immunol 1986; 16: 1313–1316
   PubMed Web of Science ®Google Scholar
• Marcos MAR, Huetz F, Pereira P, Andreu J-L, Martinez AC, Coutinho A. Further evidence for coelomic-associated B lymphocytes. Eur J Immunol 1989; 19: 2031–2035
   PubMedGoogle Scholar
• George J, Gilburd B, Shoenfeld Y. The emerging concept of pathogenic natural autoantibodies. Hum Antibodies 1997; 8: 70–75
   PubMedGoogle Scholar
• Miller DJ, Rodriguez M. A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes. J Immunol 1995; 154: 2460–2469
   PubMed Web of Science ®Google Scholar
• Asakura K, Miller DJ, Pogulis RJ, Pease LR, Rodriguez M. Oligodendrocyte-reactive O1, O4, and HNK-1 monoclonal antibodies are encoded by germline immunoglobulin genes. Brain Res Mol Brain Res 1995; 34: 283–293
   PubMedGoogle Scholar
• Kirschning E, Jensen K, Dübel S, Rutter G, Hohenberg H, Will H. Primary structure of the antigen-binding domains of a human oligodendrocyte-reactive IgM monoclonal antibody derived from a patient with multiple sclerosis. J Neuroimmunol 1999; 99: 122–130
   PubMed Web of Science ®Google Scholar
• Shirai T, Okada T, Hirose S. Genetic regulation of CD5+ B cells in autoimmune disease and in chronic lymphocytic leukemia. Ann N Y Acad Sci 1992; 651: 509–526
   PubMed Web of Science ®Google Scholar
• Plater-Zyberk C, Maini RN, Lam K, Kennedy TD, Janossy G. A rheumatoid arthritis B cell subset expresses a phenotype similar to that in chronic lymphocytic leukemia. Arthritis Rheum 1985; 28: 971–976
   PubMed Web of Science ®Google Scholar
• Hayakawa K, Hardy RR, Parks DR, Herzenberg LA. The “Ly-1 B” cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med 1983; 157: 202–218
   PubMed Web of Science ®Google Scholar
• Murakami M, Yoshioka H, Shirai T, Tsubata T, Honjo T. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int Immunol 1995; 7: 877–882
   PubMed Web of Science ®Google Scholar
• Reap EA, Sobel ES, Cohen PL, Eisenberg RA. Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice. J Exp Med 1993; 177: 69–78
   PubMedGoogle Scholar
• Reap EA, Sobel ES, Jennette JC, Cohen PL, Eisenberg RA. Conventional B cells, not B1 cells, are the source of autoantibodies in chronic graft-versus-host disease. J Immunol 1993; 151: 7316–7323
   PubMed Web of Science ®Google Scholar
• Matsiota P, Blancher A, Doyon B, Guilbert B, Clanet M, Kouvelas ED, Avrameas S. Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases. Ann Inst Pasteur Immunol 1988; 139: 99–108
   PubMedGoogle Scholar
• Xiao BG, Linington C, Link H. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J Neuroimmunol 1991; 31: 91–96
   PubMed Web of Science ®Google Scholar
• Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H. Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination. Ann Neurol 1998; 43: 465–471
   PubMed Web of Science ®Google Scholar
• Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M. Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 1994; 14: 6230–6238
   PubMed Web of Science ®Google Scholar
• Asakura K, Miller DJ, Pease LR, Rodriguez M. Targeting of IgMκ antibodies to oligodendrocytes promotes CNS remyelination. J Neurosci 1998; 18: 7700–7708
   PubMed Web of Science ®Google Scholar
• Warrington AE, Asakura K, Bieber AJ, Ciric B, Van Keulen V, Kaveri SV, Kyle RA, Pease LR, Rodriguez M. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci USA 2000; 97: 6820–6825
   PubMed Web of Science ®Google Scholar
• Correale J, Mix E, Olsson T, Kostulas V, Fredrikson S, Hojeberg B, Link H. CD5+ B cells and CD4− 8− T cells in neuroimmunological diseases. J Neuroimmunol 1991; 32: 123–132
   PubMed Web of Science ®Google Scholar
• Mix E, Olsson T, Correale J, Baig S, Kostulas V, Olsson O, Link H. B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol 1990; 79: 21–27
   PubMed Web of Science ®Google Scholar
• Seidi OA, Semra YK, Sharief MK. Expression of CD5 on B lymphocytes correlates with disease activity in patients with multiple sclerosis. J Neuroimmunol 2002; 133: 205–210
   PubMed Web of Science ®Google Scholar
• Bongioanni P, Fioretti C, Vanacore R, Bianchi F, Lombardo F, Ambrogi F, Meucci G. Lymphocyte subsets in multiple sclerosis. A study with two-colour fluorescence analysis. J Neurol Sci 1996; 139: 71–77
   PubMed Web of Science ®Google Scholar
• Sellebjerg F, Jensen J, Jensen CV, Wiik A. Expansion of CD5− B cells in multiple sclerosis correlates with CD80 (B7-1) expression. Scand J Immunol 2002; 56: 101–107
   PubMedGoogle Scholar
• Kasaian MT, Ikematsu H, Casali P. Identification and analysis of a novel human surface CD5− B lymphocyte subset producing natural antibodies. J Immunol 1992; 148: 2690–2702
   PubMed Web of Science ®Google Scholar
• Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol 2001; 19: 595–621
   PubMed Web of Science ®Google Scholar
• Hayakawa K, Shinton SA, Asano M, Hardy RR. B-1 cell definition. Curr Top Microbiol Immunol 2000; 252: 15–22
   PubMedGoogle Scholar
• Tsunoda I, Kuang L-Q, Theil DJ, Fujinami RS. Antibody association with a novel model for primary progressive multiple sclerosis: Induction of relapsing-remitting and progressive forms of EAE in H2S mouse strains. Brain Pathol 2000; 10: 402–418
   PubMed Web of Science ®Google Scholar
• Peterson LK, Tsunoda I, Masaki T, Fujinami RS. Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis. J Neuroimmunol 2007; 183: 69–80
   PubMed Web of Science ®Google Scholar
• Libbey JE, Peterson LK, Tsunoda I, Fujinami RS. Monoclonal MOG-reactive autoantibody from progressive EAE has the characteristics of a natural antibody. J Neuroimmunol 2006; 173: 135–145
   PubMedGoogle Scholar
• Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu J-M, Baker D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 1994; 153: 4349–4356
   PubMed Web of Science ®Google Scholar
• Papenfuss TL, Rogers CJ, Gienapp I, Yurrita M, McClain M, Damico N, Valo J, Song F, Whitacre CC. Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J Neuroimmunol 2004; 150: 59–69
   PubMed Web of Science ®Google Scholar
• Tsunoda I, Kuang L-Q, Tolley ND, Whitton JL, Fujinami RS. Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J Neuropathol Exp Neurol 1998; 57: 758–767
   PubMed Web of Science ®Google Scholar
• Greer JM, Sobel RA, Sette A, Southwood S, Lees MB, Kuchroo VK. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J Immunol 1996; 156: 371–379
   PubMed Web of Science ®Google Scholar
• Tsunoda I, Kuang L-Q, Igenge IZM, Fujinami RS. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation. J Neuroimmunol 2005; 160: 122–134
   PubMedGoogle Scholar
• Mi W, Prentice TW, Young CR, Johnson RR, Sieve AN, Meagher MW, Welsh CJ. Restraint stress decreases virus-induced pro-inflammatory cytokine mRNA expression during acute Theiler's virus infection. J Neuroimmunol 2006; 178: 49–61
   PubMed Web of Science ®Google Scholar
• Hayakawa K, Hardy RR, Herzenberg LA. Peritoneal Ly-1 B cells: Genetic control, autoantibody production, increased lambda light chain expression. Eur J Immunol 1986; 16: 450–456
   PubMed Web of Science ®Google Scholar
• Litzenburger T, Fassler R, Bauer J, Lassmann H, Linington C, Wekerle H, Iglesias A. B lymphocytes producing demyelinating autoantibodies: Development and function in gene-targeted transgenic mice. J Exp Med 1998; 188: 169–180
   PubMedGoogle Scholar